An experimental gene therapy could offer new hope for patients living with retinitis pigmentosa, a group of inherited retinal diseases that can lead to progressive vision loss. Sulagna Bhattacharya, co founder and CEO of Nano Scope Therapeutics, shares how her own family’s experience with RP inspired her mission to develop new treatment options.
Bhattacharya explains why retinitis pigmentosa has been particularly challenging to treat. Because...
Sophie Guibaud, nominee director, IFC, and co-chair of the Saudi chapter of the Mena Fintech Association, breaks down the rise of embedded finance across...
Bitcoin is facing another major test as the cryptocurrency falls below its 200-week moving average following a wave of liquidations, pushing prices toward the...
Tokenization is moving from a blockchain experiment to a major strategy for Wall Street, with platforms and exchanges exploring digital versions of traditional assets....
The 2026 IPO market is entering a new phase as investors await some of the biggest technology listings in history. While SpaceX’s blockbuster public...
Perder el trabajo genera pánico — pero los primeros pasos que das en esas primeras semanas determinan cuánto tiempo tardarás en reincorporarte al mercado...
AI continues to drive markets as semiconductor stocks remain at the center of investor attention. In this interview, Hardika Singh, Economic Strategist at Fundstrat,...
El mercado laboral está cambiando — y muchas familias se preguntan qué pasaría si pierden su fuente de ingresos. Otto Rivera, experto en planificación...
Rumble is evolving from a video platform into a broader technology and AI infrastructure company. In this interview from the New York Stock Exchange,...
Stergios Voskopoulos, Co-Founder and CEO of AltNovel, joins FinTech TV to explain why private wealth is systematically underallocated to private markets, and how his...
Nauman Hassan, Regional Director for MENA at Paymentology and member of the MENA Fintech Association, joins Raghda Ibraheem at FinTech TV to break down...